Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Remimazolam for Postoperative Sleep Disturbance in Oocyte Retrieval
NCT06284668Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Mar 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Postoperative sleep disturbance (PSD) and anxiety disorder comparing Placebo, Esketamine and Remimazolam (3 arms). Primary endpoint: The incidence of postoperative sleep disturbance on the first night after surgery. Started Mar 2024; status: completed.
02
Drugs
esketamineremimazolam
03
Conditions
Postoperative sleep disturbance (PSD)anxiety disorder
Beyond the preview
Go deeper on NCT06284668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06284668.